Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of EP4 receptor antagonists in the treatment of cartilage disease

Use of EP4 receptor antagonists in the treatment of cartilage disease

US Patent 10786490 · Granted Sep 29, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective EP4 receptor antagonistic substance for treatment of cancer2023
EP4 inhibitors and use thereof2021
Selective EP4 receptor antagonistic substance for treatment of cancer2021
Selective EP4 receptor antagonistic substance for treatment of cancer2020
Use of EP4 receptor antagonists for the treatment of NASH-associated liver cance2020
Use of EP4 receptor antagonists in the treatment of cartilage disease2019
Use of EP4 receptor antagonists for the treatment of NASH-associated liver cance2019
Selective EP4 receptor antagonistic substance for treatment of cancer2017
Therapeutic agent for ocular disease2017
Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases2016
Salts and crystal forms2016
Selective EP4 receptor antagonistic substance for treatment of cancer2014